Trial Profile
Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa Sachets versus Pentasa tbl. 500mg in Children with Crohns Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2022
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Mesalazine
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 31 Mar 2022 Status changed from recruiting to completed.
- 27 Jul 2011 New trial record